MARKET

SIGA

SIGA

SIGA Tech
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.610
-0.120
-2.54%
Opening 10:38 02/24 EST
OPEN
4.590
PREV CLOSE
4.730
HIGH
4.700
LOW
4.490
VOLUME
39.30K
TURNOVER
--
52 WEEK HIGH
7.03
52 WEEK LOW
4.210
MARKET CAP
373.75M
P/E (TTM)
7.43
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of SIGA and other stocks commission-free!

Open a Webull account and fund it to get a free stock

SIGA News

More
  • SIGA to Host Business Update Call on March 5, 2020 after Release of Year End Financial Results
  • GlobeNewswire · 3d ago
  • Hedge Funds Are Betting On SIGA Technologies Inc. (SIGA)
  • Insider Monkey · 12/19/2019 23:08
  • SIGA Announces Canadian Department Of National Defence Intent To Purchase Up To 15,325 Courses Of Oral TPOXX
  • Benzinga · 12/05/2019 17:14
  • SIGA Announces Canadian Department of National Defence Intent to Purchase Up To 15,325 Courses of Oral TPOXX®
  • GlobeNewswire · 12/05/2019 17:10

Industry

Pharmaceuticals
-2.21%
Pharmaceuticals & Medical Research
-2.25%

Hot Stocks

Symbol
Price
%Change
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%

About SIGA

SIGA Technologies, Inc. is a commercial-stage pharmaceutical company focused on health security market. The Company’s lead product TPOXX is approved by the Unites States Food and Drug Administration (FDA) as a drug with an indication for treatment of smallpox. TPOXX is an oral formulation, which is also known as tecovirimat and ST-246. The Company is developing the intravenous (IV) formulation for patients who are unable to swallow oral capsules. It is also focused on developing post-exposure prophylaxis (PEP), liquid suspension pediatric formulation and ST-357. PEP regimens are designed to prevent infection in individuals who have known or exposure to an infectious agent but are not symptomatic. The Company is developing a second mechanism of action smallpox small molecule antiviral drug that has shown efficacy in animal models of the disease.
More

Webull offers kinds of SIGA Technologies, Inc. stock information, including NASDAQ:SIGA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SIGA stock news, and many more online research tools to help you make informed decisions.